Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tannapfel, A
Right arrow Articles by Wittekind, C
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tannapfel, A
Right arrow Articles by Wittekind, C
Molecular Pathology 2002;55:379-384
© 2002 Journal of Clinical Pathology


ORIGINAL ARTICLE

INK4a-ARF alterations in liver cell adenoma

A Tannapfel1, C Busse1, F Geißler2, H Witzigmann2, J Hauss2 and C Wittekind1

1 Institute of Pathology, University of Leipzig, Liebigstr 26, 04103 Leipzig, Germany
2 Department of Abdominal, Vascular, and Transplantation Surgery II, University of Leipzig, Liebigstr 20a, 04103 Leipzig, Germany

Correspondence to:
Dr A Tannapfel, Institute of Pathology, University of Leipzig, Liebigstraße 26, 04103 Leipzig, Germany; tana{at}medizin.uni-leipzig.de

Background: The INK4a-ARF (CDKN2A) locus on chromosome 9p21 encodes two tumour suppressor proteins, p16INK4a and p14ARF, whose functions are inactivated in many human cancers.

Aims: To evaluate p14ARF and p16INK4a alterations in liver cell adenoma.

Methods: After microdissection, DNA from 25 liver cell adenomas and corresponding normal liver tissue were analysed for INK4-ARF inactivation by DNA sequence analysis, methylation specific polymerase chain reaction, restriction enzyme related-polymerase chain reaction (RE-PCR), mRNA expression, microsatellite analysis, and immunohistochemistry. In addition, microdeletion of p14ARF and p16INK4a were assessed by differential PCR.

Results: Methylation of p14ARF was found in 3/25 cases (12%) and alterations in p16INK4a occurred in 6/25 liver cell adenomas (24%) which correlated with loss of mRNA transcription. We failed to detect microdeletions or specific mutations of both exons. p16INK4a methylation appeared in the context of an unmethylated p14ARF promoter in six cases. In normal liver tissue, p14ARF or p16INK4a alterations were not observed.

Conclusions: Our data suggest that p14ARF methylation occurs independently of p16INK4a alterations in liver cell adenomas. Furthermore, methylation of p14ARF and p16INK4a may be a result of cell cycle deregulation and does not seem to be a prerequisite of malignancy.


Keywords: liver cell adenoma; p14ARF; p16INK4a; methylation; cell cycle deregulation

Abbreviations: LCA, liver cell adenoma; MSP, methylation specific polymerase chain reaction; RE-PCR, restriction enzyme-related polymerase chain reaction; RT-PCR, reverse transcription-polymerase chain reaction; SSCP, single strand conformational polymorphism







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.